Abstracts of Presentations from the 2020 Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat the Acute and Chronic Effects of Ocular Chemical Toxicity, 25-26 February, Bethesda, Maryland.

Yeung, David T; Araj, Houmam; McNutt, Patrick M

Yeung, David T; Araj, Houmam; McNutt, Patrick M.

Afiliação

Yeung DT; Department of Health and Human Services, National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), 5601 Fishers Lane (1G58), Bethesda, MA, 20892, USA. Electronic address: dy70v@nih.gov.
Araj H; Department of Health and Human Services, National Eye Institute/National Institutes of Health (NEI/NIH), 6700B Rockledge Dr (Suite 3400), Bethesda, MA, 20817, USA. Electronic address: houmam.araj@nih.gov.
McNutt PM; Department of Defense, United States Army Medical Research Institute of Chemical Defense (USAMRICD), 2900 Ricketts Point Road, Aberdeen Proving Ground, MA, 21010, USA. Electronic address: patrick.m.mcnutt2.civ@mail.mil.

Toxicol Lett ; : 1-3, 2020 May 25.

Article em En | MEDLINE | ID: mdl-32464237

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Toxicol Lett Ano de publicação: 2020 Tipo de documento: Article